<DOC>
	<DOCNO>NCT00946374</DOCNO>
	<brief_summary>The purpose study improve overall survival Mantle-Cell-Lymphoma ( MCL ) new concept treatment primary curative intention consist six course immunochemotherapy follow high-dose chemotherapy autologous stem cell transplantation ( SCT ) HLA-identical allogenic SCT dose-reduced conditioning regimen total body irradiation ( TBI ) 2 Gy Fludarabine young patient primary Mantle-Cell-Lymphoma</brief_summary>
	<brief_title>Prospective Trial Immunochemotherapy Plus Autologous Stem Cell Transplantation ( SCT ) Allogenic SCT Primary Mantle-Cell-Lymphoma</brief_title>
	<detailed_description>With median overall survival approximately 3 year , MCL poor prognosis NHL entity . No potentially curative therapy establish yet even intensive therapy include high-dose chemotherapy plus autologous SCT show moderate improvement prognosis MCL . Allogenic SCT seem immunological mechanism action NHL , commonly know Graft-versus-Lymphoma effect . This trial´s purpose improve overall survival patient young 55 year primary MCL sequentially combine autologous SCT allogenic SCT application 6 course immunochemotherapy high-dose chemotherapy .</detailed_description>
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Lymphoma , Mantle-Cell</mesh_term>
	<criteria>1 . First diagnosis MantleCellLymphoma without previous therapy except prephase treatment consist steroid 2 . Age 18 55 year 3 . Confirmed CD20expression lymphocytes 4 . Effective method contraception negative pregnancy test 5 . Sufficient compliance 6 . Written patient´s inform consent 1 . Manifest cardiac insufficiency , compensate 2 . Congestive Cardiomyopathy 3 . Chronic pulmonary disease include hypoxemia 4 . Severe hypertension , condensable drug 5 . Severe diabetes mellitus condensable drug 6 . Renal Insufficiency ( serum creatinin &gt; 2,0 mg/dl , Lymphoma relate ) 7 . Liver impairment ( Transaminases value 3 x upper normal value Bilirubin &gt; 2,0 mg/dl , Lymphoma relate ) 8 . HIVInfection 9 . Active Hepatitis BInfection continuous virostatic treatment possible 10 . Active Hepatitis CInfection 11 . Clinical sign cerebrovascular insufficiency cerebral damage 12 . Pregnancy , lactation inadequate contraception woman childbearing age 13 . Severe psychiatric disorder 14 . Transplantation past</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>July 2009</verification_date>
	<keyword>Mantle-Cell-Lymphoma</keyword>
	<keyword>MCL</keyword>
	<keyword>Non Hodgkin´s Lymphoma</keyword>
	<keyword>NHL</keyword>
	<keyword>Immunochemotherapy</keyword>
	<keyword>R-CHOP</keyword>
	<keyword>CHOP</keyword>
	<keyword>High-dose chemotherapy</keyword>
	<keyword>BEAM</keyword>
	<keyword>HD-BEAM</keyword>
	<keyword>Autologous stem cell transplantation</keyword>
	<keyword>Reduced conditioning regimen</keyword>
	<keyword>Unrelated donor</keyword>
	<keyword>Sibling donor</keyword>
	<keyword>Total Body Irradiation</keyword>
	<keyword>TBI</keyword>
	<keyword>Allogenic stem cell transplantation</keyword>
	<keyword>ABSCT</keyword>
	<keyword>ASCT</keyword>
	<keyword>Fludarabine+TBI</keyword>
</DOC>